TritonPoint Partners, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 2111167 CHEVY CHASE, MD

Position in HALO

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$239,066

-$55,236 QoQ

Shares Held

3,699

-15.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

TritonPoint Partners, LLC holds $687,376 across 4 Biotechnology names. HALO ranks #1 (34.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	3,699	$239,066
2	IMMX	Immix Biopharma, Inc.	24,526	$223,431
3	ARCT	Arcturus Therapeutics Holdings Inc.	28,072	$216,715
4	CALC	CalciMedica, Inc.	15,119	$8,164

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$239,066	3,699	-15.4%	Shares	Sole	2026-04-28
2025-12-31	$294,302	4,373	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.